• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
41.27
79.3
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Aditya Vision standalone net profit rises 35.98% in the March 2026 quarter
May 08,2026
Net profit of Aditya Vision rose 35.98% to Rs 21.73 crore in the quarter ended March 2026 as against Rs 15.98 crore during the previous quarter ended March 2025. Sales rose 28.42% to Rs 625.03 crore in the quarter ended March 2026 as against Rs 486.69 crore during the previous quarter ended March 2025.

For the full year,net profit rose 10.84% to Rs 116.92 crore in the year ended March 2026 as against Rs 105.49 crore during the previous year ended March 2025. Sales rose 18.23% to Rs 2671.62 crore in the year ended March 2026 as against Rs 2259.77 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales625.03486.69 28 2671.622259.77 18
OPM %8.088.69 -8.539.03 -
PBDT41.3234.06 21 198.88180.14 10
PBT30.6724.12 27 158.42143.12 11
NP21.7315.98 36 116.92105.49 11